Nova Biomedical StatStrip ketone test strips: disruption to blood
OFFICIAL-SOURCE RECALL · UNITED KINGDOM
Class 2 Medicines : Norgine Pharmaceuticals Limited, Pedmarqsi 80 Recall: Norgine Pharmaceuticals Limited is
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CountryUnited KingdomPublishedOctober 12, 2026Last updatedOctober 12, 2026Official source last checkedOctober 12, 2026 at 10:03 AM UTC
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- Class 2 Medicines Recall: Norgine Pharmaceuticals Limited, Pedmarqsi 80 mg/mL solution for infusion, EL(26)A/42
- Manufacturer
- See official notice
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
Norgine Pharmaceuticals Limited is recalling the batches listed in the table due to risk of particulate matter being present in the product identified during routine stability investigations.
Hazard
Norgine Pharmaceuticals Limited is recalling the batches listed in the table due to risk of particulate matter being present in the product identified during routine stability investigations.
What consumers should do
s related to this issue have been reported by users. Norgine Pharmaceuticals Limited has confirmed that the issue is currently limited to the two batches in this recall. However, investigations concerning all other batches are ongoing. Advice for Healthcare Professionals: Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process. Other batches of this product remain available for continued use. Healthcare professionals are reminded of the Patient Information Leaflet instruction to inspect visually the content of the vial(s) for particulate matter and discoloration prior to administration. Inline filters may be used with this product. Advice for Patients: This is a Pharmacy and Wholesaler level recall, therefore no further action is required by patients. This product is normally administered by healthcare professionals in a hospital setting. Norgine Pharmaceuticals Limited have not received any reports of adverse reactions related to the issue. Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions shoul
Official recall notice
Class 2 Medicines Recall: Norgine Pharmaceuticals Limited, Pedmarqsi 80 mg/mL solution for infusion, EL(26)A/42
Agency: Medicines and Healthcare products Regulatory Agency
Official publication date: October 12, 2026
Read the official UK_MHRA recall notice →SCAN ONCE. KEEP WATCHING.
Keep an eye on the products at home.
Scan food and household product barcodes, save your items and get notified when a future recall may match.
